瑶宝狼疮系列药物干预系统性红斑狼疮临床观察.pdf

目 录 中文摘要 ··········································1 英文摘要 ··········································3 引 言 ···········································7 正 文 ···········································9 第一部分 中(瑶)西医对系统性红斑狼疮的研究现状 ·····9 1 西医研究现状 ····································9 2 中医研究现状 ···································11 3 瑶医研究现状 ···································12 4 结论 ···········································12 第二部分 瑶医分型治疗系统性红斑狼疮的疗效研究 ····14 1.临床资料和方法 ·································14 1.1病例来源 ········································14 1.2 诊断标准 ·······································14 1.3 纳入标准 ·······································15 1.4 排除标准 ······································15 1.5 脱落、终止治疗退出标准 ························15 1.6 研究方法 ······································16 1.7 统计学处理 ····································21 2 实验结果与分析 ·································21 2.1 一般资料分析 ··································21 2.2 病例脱落、终止治疗情况分析 ························22 2.3 治疗组、对照组疗效比较····························22 2.4 安全性指标观测 ··································26 3 讨 论 ········································27 3.1 一般资料特点 ··································27 3.2 主要证候、体征对比 ····························27 3.3 瑶医辨证分型治疗特点 ··························28 3.4 瑶医干预系统性红斑狼疮的疗效分析 ··············28 3.5 瑶药干预系统性红斑狼疮的安全性 ············29 3.6 瑶医分型治疗系统性红斑狼疮的理论依据探讨 ······29 4 存在的问题和展望 ·······························31 5 结论 ···········································32 参考文献 ·········································34 综 述 ··········································38 致 谢 ··········································47 攻读学位期间发表的学术论文目录 ···················48 作者声明 ·········································49 个人简历 ·········································50 中 文 摘 要 目 的：本项目研究重点探索以覃氏瑶医为代表的研发的“瑶宝狼 疮平胶囊”及“瑶宝狼疮饮液方”等系列药物，治疗瑶医对统性红斑狼 疮的四型：盈亏不显期、盈盛而亏不显著期、亏盛而盈不显著期及盈更 盛而亏更著期，的临床有效性和安全性；探讨瑶医在治疗系统性